Trial Profile
A 12 day placebo- and reference-controlled, double-blind, single center, randomized, phase II clinical study with an intraindividual comparison, investigating the anti-psoriatic efficacy and the tolerability of LAS41002 lotion in a psoriasis plaque test
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2011
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 21 Jun 2011 New trial record